Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Journal of Cell Science
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Journal of Cell Science

  • Log in
Advanced search

RSS   Twitter  Facebook   YouTube  

  • Home
  • Articles
    • Accepted manuscripts
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Special issues
    • Subject collections
    • Cell Scientists to Watch
    • First Person
    • Sign up for alerts
  • About us
    • About JCS
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Fast-track manuscripts
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • JCS Prize
    • Manuscript transfer network
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contacts
    • Contact JCS
    • Subscriptions
    • Advertising
    • Feedback
Cell Science at a Glance
The Bcl-2-regulated apoptotic pathway
Simon Willis, Catherine L. Day, Mark G. Hinds, David C.S. Huang
Journal of Cell Science 2003 116: 4053-4056; doi: 10.1242/jcs.00754
Simon Willis
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Catherine L. Day
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark G. Hinds
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David C.S. Huang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & tables
  • Info & metrics
  • PDF
Loading

Apoptosis (programmed cell death) is required for the removal of infected, damaged or unwanted cells and its disrupted regulation is implicated in cancer, autoimmunity and degenerative disorders. At the molecular level, multiple signaling pathways converge on a family of cysteine proteases (caspases), which when activated cause cellular destruction by cleaving a range of vital cellular substrates. The Bcl-2 family of proteins are key regulators of many, but not all, signals leading to caspase activation. Here we highlight their features, which are extensively discussed in many notable reviews (see Borner, 2003; Cory and Adams, 2002; Cory et al., 2003; Gross et al., 1999; Strasser et al., 2000).

Evolutionary conservation of the cell death machinery from worms to man

Bcl-2 related proteins form part of the core apoptotic machinery conserved in species as diverse as Caenorhabditis elegans and mammals. Functionally, the Bcl-2-related proteins either inhibit or promote apoptosis, and interaction(s) between proteins belonging to opposing factions determines whether a cell lives or dies. Perhaps the best understood pathway is that in the worm C. elegans, where detailed genetic studies have shown that two Bcl-2 related proteins (pro-apoptotic EGL-1 and pro-survival CED-9) are essential for controlling developmentally programmed somatic cell deaths (Horvitz, 1999). Expression of EGL-1, the death trigger, is induced by damage signals. Binding of EGL-1 to CED-9, the worm Bcl-2 ortholog, releases the adapter protein CED-4 from CED-9. Once released, CED-4 binds to and activates the caspase CED-3 to cause cellular demise.⇓

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

(See poster insert)

Conserved domains characterize the family

Mammals bear at least five homologs of pro-survival CED-9, namely Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and A1: all inhibit apoptosis during development and in response to cellular stress. They share with CED-9 at least three conserved BH (Bcl-2 homology) domains. Three of these (BH1, BH2 and BH3) fold together to form a hydrophobic groove on the pro-survival molecules (Muchmore et al., 1996). This groove is the target for ligand binding by pro-apoptotic EGL-1 or its mammalian counterparts Bik/Nbk/Blk, Bid, Bad, Hrk/DP5, Bim/Bod, Noxa, Puma/Bbc3, Bmf and Bcl-Gs. These killer proteins (BH3-only proteins) share the short BH3 domain, but no other notable sequences, with the wider Bcl-2 family (Huang and Strasser, 2000). Binding of BH3-only proteins to their cognate partners occurs through the interaction between the hydrophobic face formed by amphipathic α-helical BH3 domain and the hydrophobic groove (formed by BH1-BH3) of the pro-survival proteins (Petros et al., 2000; Sattler et al., 1997). In addition to the BH3-only proteins, the other class of pro-apoptotic Bcl-2 proteins is the multi-domain Bax-like proteins. They have remarkable sequence and structural similarity to their pro-survival cousins (Suzuki et al., 2000) but function instead to promote cell death, probably at a step distinct from the BH3-only proteins.

BH3-only proteins: sensors of cellular well-being

Biochemical and genetic experiments have suggested that the BH3-only proteins function as cell death triggers (Huang and Strasser, 2000). For example, loss of EGL-1 or Bim leads to excess cells during development, and their resistance to many damage signals. In order to prevent inappropriate cell deaths, the BH3-only proteins are held in check by a number of mechanisms until cellular insult relieves the brakes (Puthalakath and Strasser, 2002). In the hermaphrodite-specific neurons of C. elegans, transcription of EGL-1 is repressed by TRA-1A until this is removed by developmental cues (Conradt and Horvitz, 1999). Transcriptional control of mammalian BH3-only proteins has also been described for Hrk/DP5, Bim, Noxa and Puma. The latter two proteins may be key mediators of cell death induced by the tumor suppressor protein p53 in response to DNA damage (e.g. Nakano and Vousden, 2001). Post-transcriptional controls, by sequestration or protein modification, have also been described. Bim and Bmf are sequestered to the cytoskeletal structures and stress signals trigger their release, perhaps by inducing their phosphorylation (Lei and Davis, 2003). In contrast, survival factors inactivate Bad in healthy cells by phosphorylation that promotes its binding to 14-3-3 scaffold proteins. Full-length Bid appears to have little activity, but cleavage by caspases produces an active C-terminal fragment (tBid) that is a potent killer when targeted to the mitochondria by myristoylation of its N-terminus.

Activation of caspases, the cell death executioners

The different mammalian BH3-only proteins are coupled to distinct (but overlapping) stress signaling pathways. When damage signals remove the normal controls imposed on them, they are released to bind and inactivate pro-survival Bcl-2 proteins. This cellular switch may be partly regulated by the location of these proteins as BH3-only proteins target pro-survival Bcl-2 proteins located on the cytoplasmic face of the nuclear envelope, endoplasmic reticulum and outer mitochondrial membranes. Most attention has focused on the role of Bcl-2 proteins on mitochondria because when the outer mitochondrial membrane is breached, pro-apoptogenic factors such as cytochrome c, Smac/Diablo and HtrA2/Omi are released from the mitochondrial inter-membrane space (Martinou and Green, 2001). Cytochrome c triggers the formation of a holoenzyme ('apoptosome') with Apaf-1, the sole mammalian CED-4 homolog discovered to date, and the initiator caspase, caspase-9, to activate downstream caspases (Zou et al., 1997). However, mammalian pro-survival Bcl-2 proteins do not function to directly sequester Apaf-1, unlike C. elegans CED-9 sequestering CED-4 (Moriishi et al., 1999). Furthermore, the cytochrome c/Apaf-1/Caspase-9 pathway activated by stress signals does not appear to be the sole route for caspase activation in many cell types (Marsden et al., 2002). Thus, Bcl-2 must control step(s) upstream of, and in addition to, the release of mitochondrial cytochrome c (Cory and Adams, 2002).

Multi-domain Bax-like proteins

The multi-domain Bax-like sub-family may be responsible for damaging the outer mitochondrial membrane, permitting release of factors such as cytochrome c, although how this occurs is controversial (Kuwana et al., 2002; Roucou et al., 2002). Bax and Bak are functionally redundant as loss of either protein alone causes mild abnormalities, but their combined loss causes marked accumulation of redundant tissues (Lindsten et al., 2000). Interestingly, killing by BH3-only proteins is also abrogated (Cheng et al., 2001; Zong et al., 2001), but it is unclear whether BH3-only proteins act directly on Bax/Bak to activate them. Such a model appears attractive because Bax also bears a hydrophobic groove that may be the real target for binding, and consequent killing, by BH3-only proteins. BH3 binding may promote the membrane translocation of cytosolic Bax, its conformational alteration and aggregation, events associated with Bax activation. Surprisingly little data supports direct binding of BH3-only proteins to Bax/Bak (Wang et al., 1996; Wei et al., 2000) or their presence in Bax/Bak-containing complexes (Antonsson et al., 2001; Nechushtan et al., 2001). An alternative possibility is that pro-survival Bcl-2-like proteins control Bax/Bak activation directly or indirectly: BH3 binding abolishes this activity thereby permitting Bax/Bak activation.

Sticky tails on the road to a sticky end

How might BH3-binding abrogate the activity of pro-survival Bcl-2? In addition to the conserved hydrophobic groove formed by BH1-BH3 on pro-survival Bcl-2 targeted for BH3 binding, most of the pro-survival molecules also have a C-terminal hydrophobic region. Although this region may function as a transmembrane domain allowing membrane insertion, the 3D structure of pro-survival Bcl-w reveals that the hydrophobic tail is not normally exposed but instead occupies the hydrophobic groove targeted by BH3-only ligands (Denisov et al., 2003; Hinds et al., 2003). BH3 binding would displace the tail permitting tighter membrane interaction and this step inactivates the pro-survival molecule (Wilson-Annan et al., 2003). A similar mechanism has been proposed to activate Bax as its C-terminus, which is required for biological activity and is not normally exposed (Suzuki et al., 2000). As discussed, the direct trigger for releasing the tail of Bax and its membrane translocation is unknown (Guo et al., 2003). Understanding how BH3-only proteins inactivate Bcl-2 and how this leads to the activation of Bax/Bak may be the key to understanding the function of these proteins.

Perspectives

Ever since the cloning of Bcl-2 and the discovery of its biological function (Vaux et al., 1988), the Bcl-2 family of proteins have been shown to be key regulators of apoptosis and tremendous advances have occurred in understanding the underlying molecular mechanisms of cell death control. However, many questions remain. Are the proteins of each class functionally equivalent (Nijhawan et al., 2003)? How does pro-survival Bcl-2 function? Do Bcl-2 and its pro-survival homologs, like C. elegans CED-9, directly control mammalian CED-4 orthologs, since over-expression of human Bcl-2 in worms can compensate for the loss of CED-9 (Hengartner and Horvitz, 1994)? Alternatively, does Bcl-2 directly control the integrity of mitochondrial and other intracellular membranes (Kaufmann et al., 2003; Scorrano et al., 2003)? Could this family of proteins control membrane integrity indirectly, by impinging on membrane fusion and fission (Karbowski et al., 2002)? Does Bcl-2 function only to act as a `sink' for BH3-only proteins thereby preventing Bax/Bak activation, the real targets for BH3-only ligands (Letai et al., 2002)? Alternatively, could Bcl-2 control the activation of Bax/Bak by other mechanisms and, if so, why does human Bcl-2 function in worms, which have no apparent Bax-like orthologs? Do BH3-only proteins kill solely by binding to pro-survival Bcl-2, or is there a yet to be identified target for them? The coming years offer exciting possibilities for further insight as more of this ancient, essential and ultimately fascinating cellular process is unraveled.

Acknowledgements

Work in our laboratories is supported by grants and fellowships from the NHMRC (Australia, 257502), the US NCI (CA80188 and CA43540), the Leukemia & Lymphoma Society of America (Specialized Center of Research; 7015-02), the Marsden Fund (NZ) and the Sylvia & Charles Viertel Charitable Foundation (Australia). We thank our many colleagues especially J. Adams, P. Bouillet, S. Cory, H. Puthalakath, A. Strasser and D. Vaux for their continuing input into our work. We apologize to the many scientists and colleagues who are not cited owing to space limitations.

  • © The Company of Biologists Limited 2003

References

  1. ↵
    Antonsson, B., Montessuit, S., Sanchez, B. and Martinou, J. C. (2001). Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276, 11615-11623.
    OpenUrlAbstract/FREE Full Text
  2. ↵
    Borner, C. (2003). The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions. Mol. Immunol. 39, 615-647.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    Cheng, E. H., Wei, M. C., Weiler, S., Flavell, R. A., Mak, T. W., Lindsten, T. and Korsmeyer, S. J. (2001). BCL-2, BCL-xL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis. Mol. Cell 8, 705-711.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Conradt, B. and Horvitz, H. R. (1999). The TRA-1A sex determination protein of C. elegans regulates sexually dimorphic cell deaths by repressing the egl-1 cell death activator gene. Cell 98, 317-327.
    OpenUrlCrossRefPubMedWeb of Science
  5. ↵
    Cory, S. and Adams, J. M. (2002). The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647-656.
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Cory, S., Huang, D. C. S. and Adams, J. M. (2003). The Bcl-2 Family: Role in cell survival and oncogenesis. Oncogene (in press).
  7. ↵
    Denisov, A. Y., Madiraju, M. S., Chen, G., Khadir, A., Beauparlant, P., Attardo, G., Shore, G. C. and Gehring, K. (2003). Solution structure of human BCL-w: modulation of ligand binding by the C-terminal helix. J. Biol. Chem. 278, 21124-21128.
    OpenUrlAbstract/FREE Full Text
  8. ↵
    Gross, A., McDonnell, J. M. and Korsmeyer, S. J. (1999). Bcl-2 family members and the mitochondria in apoptosis. Genes Dev. 13, 1899-1911.
    OpenUrlFREE Full Text
  9. ↵
    Guo, B., Zhai, D., Cabezas, E., Welsh, K., Nouraini, S., Satterthwait, A. C. and Reed, J. C. (2003). Humanin peptide suppresses apoptosis by interfering with Bax activation. Nature 387, 535-636.
    OpenUrl
  10. ↵
    Hengartner, M. O. and Horvitz, H. R. (1994). C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian protooncogene bcl-2. Cell 76, 665-676.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    Hinds, M. G., Lackmann, M., Skea, G. L., Harrison, P. J., Huang, D. C. S. and Day, C. L. (2003). The structure of Bcl-w reveals a role for the C-terminal residues in modulating biological activity. EMBO J. 22, 1497-1507.
    OpenUrlAbstract
  12. ↵
    Horvitz, H. R. (1999). Genetic control of programmed cell death in the nematode Caenorhabditis elegans. Cancer Res. 59, 1701s-1706s.
    OpenUrlFREE Full Text
  13. ↵
    Huang, D. C. S. and Strasser, A. (2000). BH3-only proteins-essential initiators of apoptotic cell death. Cell 103, 839-842.
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Karbowski, M., Lee, Y. J., Gaume, B., Jeong, S. Y., Frank, S., Nechushtan, A., Santel, A., Fuller, M., Smith, C. L. and Youle, R. J. (2002). Spatial and temporal association of Bax with mitochondrial fission sites, Drp1, and Mfn2 during apoptosis. J. Cell Biol. 159, 931-938.
    OpenUrlAbstract/FREE Full Text
  15. ↵
    Kaufmann, T., Schlipf, S., Sanz, J., Neubert, K., Stein, R. and Borner, C. (2003). Characterization of the signal that directs Bcl-xL, but not Bcl-2, to the mitochondrial outer membrane. J. Cell Biol. 160, 53-64.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Kuwana, T., Mackey, M. R., Perkins, G., Ellisman, M. H., Latterich, M., Schneiter, R., Green, D. R. and Newmeyer, D. D. (2002). Bid, Bax, and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111, 331-342.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    Lei, K. and Davis, R. J. (2003). JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis. Proc. Natl. Acad. Sci. USA 100, 2432-2437.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    Letai, A., Bassik, M., Walensky, L., Sorcinelli, M., Weiler, S. and Korsmeyer, S. (2002). Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2, 183-192.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    Lindsten, T., Ross, A. J., King, A., Zong, W., Rathmell, J. C., Shiels, H. A., Ulrich, E., Waymire, K. G., Mahar, P., Frauwirth, K. et al. (2000). The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol. Cell 6, 1389-1399.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    Marsden, V., O'Connor, L., O'Reilly, L. A., Silke, J., Metcalf, D., Ekert, P., Huang, D. C. S., Cecconi, F., Kuida, K., Tomaselli, K. J. et al. (2002). Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature 419, 634-637.
    OpenUrlCrossRefPubMedWeb of Science
  21. ↵
    Martinou, J.-C. and Green, D. R. (2001). Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2, 63-67.
    OpenUrlCrossRefPubMedWeb of Science
  22. ↵
    Moriishi, K., Huang, D. C. S., Cory, S. and Adams, J. M. (1999). Bcl-2 family members do not inhibit apoptosis by binding the caspase-activator Apaf-1. Proc. Natl. Acad. Sci. USA 96, 9683-9688.
    OpenUrlAbstract/FREE Full Text
  23. ↵
    Muchmore, S. W., Sattler, M., Liang, H., Meadows, R. P., Harlan, J. E., Yoon, H. S., Nettesheim, D., Chang, B. S., Thompson, C. B., Wong, S.-L. et al. (1996). X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 381, 335-341.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    Nakano, K. and Vousden, K. H. (2001). PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7, 683-694.
    OpenUrlCrossRefPubMedWeb of Science
  25. ↵
    Nechushtan, A., Smith, C. L., Lamensdorf, I., Yoon, S. H. and Youle, R. J. (2001). Bax and Bak coalesce into novel mitochondria-associated clusters during apoptosis. J. Cell Biol. 153, 1265-1276.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F. and Wang, X. (2003). Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev. 17, 1475-1486.
    OpenUrlAbstract/FREE Full Text
  27. ↵
    Petros, A. M., Nettseheim, D. G., Wang, Y., Olejniczak, E. T., Meadows, R. P., Mack, J., Swift, K., Matayoshi, E. D., Zhang, H., Thompson, C. B. et al. (2000). Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Prot. Sci. 9, 2528-2534.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    Puthalakath, H. and Strasser, A. (2002). Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9, 505-512.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    Roucou, X., Montessuit, S., Antonsson, B. and Martinou, J. C. (2002). Bax oligomerization in mitochondrial membranes requires tBid (caspase-8-cleaved Bid) and a mitochondrial protein. Biochem. J. 368, 915-921.
    OpenUrlCrossRefPubMedWeb of Science
  30. ↵
    Sattler, M., Liang, H., Nettesheim, D., Meadows, R. P., Harlan, J. E., Eberstadt, M., Yoon, H. S., Shuker, S. B., Chang, B. S., Minn, A. J. et al. (1997). Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 275, 983-986.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    Scorrano, L., Oakes, S. A., Opferman, J. T., Cheng, E. H., Sorcinelli, M. D., Pozzan, T. and Korsmeyer, S. J. (2003). BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300, 135-139.
    OpenUrlAbstract/FREE Full Text
  32. ↵
    Strasser, A., O'Connor, L. and Dixit, V. M. (2000). Apoptosis signaling. Annu. Rev. Biochem. 69, 217-245.
    OpenUrlCrossRefPubMedWeb of Science
  33. ↵
    Suzuki, M., Youle, R. J. and Tjandra, N. (2000). Structure of Bax: coregulation of dimer formation and intracellular localization. Cell 103, 645-654.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    Vaux, D. L., Cory, S. and Adams, J. M. (1988). Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335, 440-442.
    OpenUrlCrossRefPubMedWeb of Science
  35. ↵
    Wang, K., Yin, X.-M., Chao, D. T., Milliman, C. L. and Korsmeyer, S. J. (1996). BID: a novel BH3 domain-only death agonist. Genes Dev. 10, 2859-2869.
    OpenUrlAbstract/FREE Full Text
  36. ↵
    Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B. and Korsmeyer, S. J. (2000). tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c. Genes Dev. 14, 2060-2071.
    OpenUrlAbstract/FREE Full Text
  37. ↵
    Wilson-Annan, J., O'Reilly, L. A., Crawford, S. A., Hausmann, G., Beaumont, J. G., Parma, L. P., Lackmann, M., Hinds, M. G., Day, C. L., Adams, J. M. et al. (2003). Pro-apoptotic BH3-only proteins trigger tight membrane association and neutralize pro-survival Bcl-w. J. Cell Biol. (in press).
  38. ↵
    Zong, W. X., Lindsten, T., Ross, A. J., MacGregor, G. R. and Thompson, C. B. (2001). BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev. 15, 1481-1486.
    OpenUrlAbstract/FREE Full Text
  39. ↵
    Zou, H., Henzel, W. J., Liu, X., Lutschg, A. and Wang, X. (1997). Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of Caspase-3. Cell 90, 405-413.
    OpenUrlCrossRefPubMedWeb of Science
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

 Download PDF

Email

Thank you for your interest in spreading the word on Journal of Cell Science.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The Bcl-2-regulated apoptotic pathway
(Your Name) has sent you a message from Journal of Cell Science
(Your Name) thought you would like to see the Journal of Cell Science web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Cell Science at a Glance
The Bcl-2-regulated apoptotic pathway
Simon Willis, Catherine L. Day, Mark G. Hinds, David C.S. Huang
Journal of Cell Science 2003 116: 4053-4056; doi: 10.1242/jcs.00754
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Cell Science at a Glance
The Bcl-2-regulated apoptotic pathway
Simon Willis, Catherine L. Day, Mark G. Hinds, David C.S. Huang
Journal of Cell Science 2003 116: 4053-4056; doi: 10.1242/jcs.00754

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Evolutionary conservation of the cell death machinery from worms to man
    • Conserved domains characterize the family
    • BH3-only proteins: sensors of cellular well-being
    • Activation of caspases, the cell death executioners
    • Multi-domain Bax-like proteins
    • Sticky tails on the road to a sticky end
    • Perspectives
    • Acknowledgements
    • References
  • Figures & tables
  • Info & metrics
  • PDF

Related articles

Cited by...

More in this TOC section

  • Translation initiation in cancer at a glance
  • Tumour-directed microenvironment remodelling at a glance
  • FGF2 and IL-1β – explorers of unconventional secretory pathways at a glance
Show more CELL SCIENCE AT A GLANCE

Similar articles

Other journals from The Company of Biologists

Development

Journal of Experimental Biology

Disease Models & Mechanisms

Biology Open

Advertisement

2020 at The Company of Biologists

Despite the challenges of 2020, we were able to bring a number of long-term projects and new ventures to fruition. While we look forward to a new year, join us as we reflect on the triumphs of the last 12 months.


Mole – The Corona Files

"This is not going to go away, 'like a miracle.' We have to do magic. And I know we can."

Mole continues to offer his wise words to researchers on how to manage during the COVID-19 pandemic.


Cell scientist to watch – Christine Faulkner

In an interview, Christine Faulkner talks about where her interest in plant science began, how she found the transition between Australia and the UK, and shares her thoughts on virtual conferences.


Read & Publish participation extends worldwide

“The clear advantages are rapid and efficient exposure and easy access to my article around the world. I believe it is great to have this publishing option in fast-growing fields in biomedical research.”

Dr Jaceques Behmoaras (Imperial College London) shares his experience of publishing Open Access as part of our growing Read & Publish initiative. We now have over 60 institutions in 12 countries taking part – find out more and view our full list of participating institutions.


JCS and COVID-19

For more information on measures Journal of Cell Science is taking to support the community during the COVID-19 pandemic, please see here.

If you have any questions or concerns, please do not hestiate to contact the Editorial Office.

Articles

  • Accepted manuscripts
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Special issues
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About Journal of Cell Science
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Fast-track manuscripts
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • JCS Prize
  • Manuscript transfer network
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contacts

  • Contact JCS
  • Subscriptions
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992